Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Rob,
Just to clarify i believe most are expecting some Q&A because the quote below is from the webinar registration page entry for Paul Langworthy:
"We will be joined live by Paul Langworthy, CEO of 7digital and he will present the most up to date iteration of the #7DIG strategy and respond to questions thereafter."
Yep I thought about this last night. If the 7p/9p options change WAS a clever SP support mechanism in advance of news, then they surely can't risk letting the initial SP momentum of the post RNS SP move dip, by leaving it more than 24hours.
We all know what happens on prolonged periods of no news.
I was actually disappointed there was no RNS this morning, so fingers crossed for this pm, it would be great to see the flow and fireworks that we all expect finally begin :-)
So the tweet may, as some think, that Vlad is just confirming that we collaberate with EL on other things. But it is also not clear and quite open to interpretation that we are now in some way involved with this Covid project. Perhaps the link i sent yesterday has some relevance to us...
https://www.nytimes.com/2020/09/16/health/coronavirus-drug-eli-lilly.html
Could be right, could be wrong, but IMO Hemo need to RNS to clarify the situation now.
Article today re: Ely lilly and Covid treatment.
https://www.nytimes.com/2020/09/16/health/coronavirus-drug-eli-lilly.html
I'm not saying HEMO are behind any of this but it is possible.
Article:
"The drug is a monoclonal antibody, a manufactured copy of an antibody produced by a patient who recovered from Covid-19, the illness caused by the coronavirus." .......
......."In six months, Eli Lilly isolated an antibody from one of the first Covid-19 survivors, turned it into a drug and began a study, enrolling the first patients on June 17. "
Hemo Covid update RNS 15th June 2020:
The work involves transplanting cells from blood samples from patients who have already recovered from COVID-19 into the ApbHC. This process will allow the Company's scientists to recreate a set of anti-SARS-CoV-2 virus antibodies which could be used for the treatment of COVID-19 sufferers.
Given the relationship between Hemo and Ely lilly, is it possible that we are involved in this?
Great list of PI holdings - Glad to be a part of this. I hope Vlad and the team are encouraged by quite a large groups of committed investors.
On another topic...has anyone else noticed that the share price appears to have stuck (on google at least) at 10.7p for 2hrs now, without a move at all.
Since 10:35am it has flatlined at 10.7p.
This seems quite odd to me. Not seen this before with any share I have watched or been involved in.
Anyone got any thoughts on this?
Best regards
Thanks Digittt.
Sorry to hear that. hope HEMO helps you recover and move forward.
FWIW i dipped into the markets around back in 2010/11 and lost pretty much the lot on RKH and VOG. Thankfully not the kitchen sink, but it was more than enough at that point in my life. So I left it all alone.
Then, like many, decided to try again after sensing an opportunity due to the lockdown market crash. Made some decent quick returns on oil stocks, but then found HEMO, started to pay attention to doing research and here we are today! Also along the way found EUA. Both doing beautifully!
Good luck.